FIELD: medicine.
SUBSTANCE: method for managing the consequences and complications of ischemia-reperfusion syndrome of mammalian kidneys based on the recombinant protein TAT-Prx2.
EFFECT: method of treatment using TAT-Prx2 ensures the most efficient protection of the renal tissue from ischemic and reperfusion damage owing to reduction of the reactive oxygen intermediate hyperproduction and preservation of the morphophysiological condition of the renal tissue.
4 cl, 9 ex., 2 tbl., 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT, USE THEREOF AND A METHOD OF INCREASING RESISTANCE OF A MAMMALIAN ORGANISM TO ISCHEMIC-REPERFUSION INVOLVEMENT OF THE SMALL INTESTINE | 2018 |
|
RU2729788C2 |
| RECOMBINANT BIFUNCTIONAL PSH PROTEIN POSSESSING ANTIOXIDANT ACTIVITY OF SUPEROXIDE DISMUTASE AND PEROXIDASE, CHIMERIC NUCLEIC ACID CODING IT, RECOMBINANT PLASMID VECTOR CONTAINING IT AND USING PSH PROTEIN IN REPERFUSION INJURY OF HEART | 2012 |
|
RU2534348C2 |
| COMPOSITION WITH ANTIOXIDANT PROPERTY AND METHOD FOR TREATMENT OF DISEASE IN MAMMALS | 2002 |
|
RU2280448C2 |
| PREVENTION/REDUCTION OF ISCHEMIA-RELATED DAMAGES | 2018 |
|
RU2768889C2 |
| METHOD FOR TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION | 2010 |
|
RU2600876C2 |
| METHOD FOR PREVENTING AND TREATING ISCHEMIA ATTACKS AND REPERFUSION INJURIES ARISING DUE TO THE ATTACK | 1994 |
|
RU2153353C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
| METHOD FOR PREVENTING RENAL DYSFUNCTION WITH AN ARGINASE II INHIBITOR IN EXPERIMENT | 2018 |
|
RU2696580C1 |
| METHOD OF TREATING REPERFUSION RENAL DAMAGES IN ONCOLOGICAL PATIENTS | 2007 |
|
RU2428211C2 |
